Henrich R. K. Guntermann
Keine laufenden Positionen mehr
Profil
Henrich R.
K.
Guntermann worked as a Director and President-Europe & Immunology Group at Nuvo Pharmaceuticals, Inc. from 2011 to 2016.
He also worked as a Director at Crescita Therapeutics, Inc. in 2016.
Guntermann holds a doctorate degree from Philipps University of Marburg.
Ehemalige bekannte Positionen von Henrich R. K. Guntermann
| Unternehmen | Position | Ende |
|---|---|---|
| CRESCITA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 29.09.2016 |
| NUVO PHARMACEUTICALS INC. | Präsident | 16.12.2009 |
Ausbildung von Henrich R. K. Guntermann
| Philipps University of Marburg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
